AT
Attovia Therapeutics, Inc.
ATTO · NASDAQ
$17.17 -3.49% (-$0.62)
1M -32.80%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 0.00x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ATTO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tao Fu
Employees
44
Headquarters
San Carlos